(Q30413592)

English

Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 September 2017

Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial) (English)

1 reference

Europe PubMed Central

15 September 2017

steatohepatitis

0 references

randomized experiment

1 reference

based on heuristic

inferred from title

Claude B. Sirlin

2

1 reference

Europe PubMed Central

15 September 2017

object named as

Mark A Valasek

19

0 references

object named as

Meng Yin

16

0 references

David A. Brenner

object named as

David A Brenner

20

0 references

author name string

Rohit Loomba

1

1 reference

Europe PubMed Central

15 September 2017

Brandon Ang

3

1 reference

Europe PubMed Central

15 September 2017

Ricki Bettencourt

4

1 reference

Europe PubMed Central

15 September 2017

Rashmi Jain

5

1 reference

Europe PubMed Central

15 September 2017

Joanie Salotti

6

1 reference

Europe PubMed Central

15 September 2017

Linda Soaft

7

1 reference

Europe PubMed Central

15 September 2017

Jonathan Hooker

8

1 reference

Europe PubMed Central

15 September 2017

Yuko Kono

9

1 reference

Europe PubMed Central

15 September 2017

Archana Bhatt

10

1 reference

Europe PubMed Central

15 September 2017

Laura Hernandez

11

1 reference

Europe PubMed Central

15 September 2017

Phirum Nguyen

12

1 reference

Europe PubMed Central

15 September 2017

Mazen Noureddin

13

1 reference

Europe PubMed Central

15 September 2017

William Haufe

14

1 reference

Europe PubMed Central

15 September 2017

Catherine Hooker

15

1 reference

Europe PubMed Central

15 September 2017

Richard Ehman

17

1 reference

Europe PubMed Central

15 September 2017

Grace Y Lin

18

1 reference

Europe PubMed Central

15 September 2017

Lisa Richards

21

1 reference

Europe PubMed Central

15 September 2017

San Diego Integrated NAFLD Research Consortium (SINC)

22

1 reference

Europe PubMed Central

15 September 2017

language of work or name

0 references

publication date

27 February 2015

1 reference

Europe PubMed Central

15 September 2017

1 reference

Europe PubMed Central

15 September 2017

61

1 reference

Europe PubMed Central

15 September 2017

4

1 reference

Europe PubMed Central

15 September 2017

1239-1250

1 reference

Europe PubMed Central

15 September 2017

randomized experiment

0 references

Effect of weight loss on magnetic resonance imaging estimation of liver fat and volume in patients with nonalcoholic steatohepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

Serum alanine aminotransferase as a biomarker of treatment response in nonalcoholic steatohepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

Use of magnetic resonance elastography to assess hepatic fibrosis in children with chronic liver disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

Magnetic resonance elastography of liver: technique, analysis, and clinical applications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic Fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

Placebo in nonalcoholic steatohepatitis: insight into natural history and implications for future clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

Assessment of hepatic fibrosis with magnetic resonance elastography

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4407930

20 June 2018

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27647

21 January 2018

Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27647

21 January 2018

Long-term follow-up of patients with nonalcoholic fatty liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27647

21 January 2018

Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27647

21 January 2018

Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27647

21 January 2018

Emerging quantitative magnetic resonance imaging biomarkers of hepatic steatosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27647

21 January 2018

The efficacy of ezetimibe on nonalcoholic fatty liver disease (NAFLD)

1 reference

https://pubmed.ncbi.nlm.nih.gov/25482832

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25482832

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of ezetimibe for reducing serum low-density lipoprotein cholesterol levels resistant to lifestyle intervention in patients with non-alcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25482832

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/HEP.27647

1 reference

Europe PubMed Central

15 September 2017

1 reference

Europe PubMed Central

15 September 2017

1 reference

Europe PubMed Central

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30413592&oldid=1606703106"